Castle Biosciences Inc
- Stock
- Ticker CSTL
- ISIN US14843C1053
- Nasdaq
Performance, volatility and drawdowns of Castle Biosciences Inc since 07/2019, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $5,270. Global equities (VT): $14,653.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −88.0% in 06/2023, measured from the peak in 02/2021. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 86 | 88 | 86 | 83 | 87 | 84 | 104 | 103 |
| Gross profit | 70 | 72 | 69 | 64 | 69 | 63 | 80 | 79 |
| Operating income | 4.1 | -28 | -4.3 | -6.8 | -3.8 | -18 | -3.1 | -2.7 |
| EBITDA | 9.8 | 1.8 | -2.8 | -5.3 | -0.1 | -14 | -1.3 | -0.7 |
| Net income | 9.6 | -26 | 4.5 | -0.5 | -2.3 | -15 | -2.1 | -4.1 |
| Earnings per share | 0.32 | -0.90 | 0.15 | -0.02 | -0.07 | -0.49 | -0.07 | -0.13 |
| Balance sheet | ||||||||
| Total assets | 531 | 502 | 545 | 563 | 579 | 548 | 561 | 579 |
| Liabilities | 75 | 61 | 89 | 96 | 108 | 86 | 91 | 101 |
| Equity | 456 | 440 | 455 | 467 | 471 | 461 | 470 | 478 |
| Cash | 120 | 90 | 82 | 86 | 117 | 64 | 62 | 78 |
| Long-term debt | 9.7 | 8.9 | 8.1 | 10 | 9.6 | 8.4 | 7.2 | 5.9 |
| Cash flow | ||||||||
| Operating cash flow | 24 | -6.0 | 21 | 23 | 27 | -22 | 15 | 20 |
| Capital expenditure | -7.6 | -4.7 | -9.3 | -15 | -7.2 | -12 | -8.7 | -7.5 |
| Free cash flow | 17 | -11 | 12 | 7.8 | 20 | -35 | 6.6 | 12 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2020 at +95.4%, weakest 2022 at −45.1%. 3 of 6 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 5 Nov 2026 | −$0.13 |
| 30 Jul 2026 | −$0.07 |
| 6 May 2026 | −$0.49 |
| 26 Feb 2026 | −$0.07 |
| 3 Nov 2025 | −$0.02 |
| 4 Aug 2025 | $0.15 |
| 5 May 2025 | −$0.90 |
| 27 Feb 2025 | $0.32 |
| 4 Nov 2024 | $0.08 |
| 5 Aug 2024 | $0.31 |
| 2 May 2024 | −$0.09 |
| 28 Feb 2024 | −$0.09 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €918m
- Market cap in trading currency
- $1.01bn
- Enterprise value
- $745m
- P/E
- –
- P/S
- 2.69
- P/B
- 2.12
- EV/Sales
- 1.98
- EV/EBITDA
- –
- Earnings yield
- –
- FCF yield
- 0.4%
Results (last four quarters)
- Revenue
- $377m
- Gross profit
- $291m
- EBITDA
- −$16.4m
- Net income
- −$23.0m
- Earnings per share
- −$0.76
- Revenue per share
- $12.24
- Revenue growth
- +23.9%
- Earnings growth
- –
Profitability
- Gross margin
- 77.1%
- Operating margin
- -7.4%
- Net margin
- -6.1%
- Return on equity
- -4.9%
- Return on assets
- -4.0%
Balance sheet and cash flow
- Cash
- $278m
- Cash per share
- $9.01
- Financial debt
- $10.1m
- Debt/equity %
- 2
- Current ratio
- 5.28
- Book value per share
- $15.52
- Operating cash flow
- $39.7m
- Free cash flow
- $3.96m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- –
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 30.8m
- Volume
- 309,215
- Avg. volume 3 months
- 384,837
- Relative volume
- 0.8
Price and technicals
- Price
- $32.86
- 1 day
- −1.6%
- 52-week high
- $43.04
- 52-week low
- $18.15
- Distance to 52-week high
- −23.7%
- Distance to 52-week low
- +81.0%
- Distance to 50-day line
- −4.5%
- Distance to 200-day line
- +17.0%
- RSI (14)
- 45
- Volatility 1M
- 53.4%
Performance
- 1 week
- −2.8%
- 1 month
- −1.0%
- 3 months
- −1.8%
- 6 months
- +63.1%
- YTD
- −15.5%
- 1 year
- −5.2%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has CSTL performed since 07/2019?
$10,000 grew to $15,355 by 20 Nov 2026, which is +6.0% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is CSTL?
Volatility was 66.1% per year, measured on monthly returns. The largest decline from a peak was −88.0%, with the low in 06/2023.
How does CSTL compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.1% per year at 16.2% volatility, CSTL returned +6.0% at 66.1%. The correlation of monthly returns was 0.23; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.